Corebridge: Cheap on the Books, Conditional on the Equitable Deal

Hook & thesis

Corebridge Financial (CRBG) offers the kind of valuation that gets value investors excited: a market cap around $12.0B, price-to-book roughly in the low single digits and a dividend yield north of 3%. Those are real, concrete anchors for a trade. But the company's near-term path is dominated by a proposed merger with Equitable Holdings and a shareholder-law-firm probe into whether the combined deal is delivering fair value. The merger turns a straightforward value story into a conditional one.

My working thesis is this: buy Corebridge on controlled weakness because the core business - retirement solutions and insurance - remains cash generative and the stock already prices modest multiples. However, treat the position as a tactical, mid-horizon trade: the equity is cheap relative to its capital base but the deal process and disclosure cadence create risk of downside volatility. That makes strict entry, stop, and target levels essential.

What Corebridge does and why the market should care

Corebridge operates across Individual Retirement (fixed annuities, fixed-index annuities, variable annuities, mutual funds), Group Retirement (record keeping, plan services, annuities), Life Insurance, and Institutional Markets. Those businesses are interest-rate and longevity-sensitive but also benefit from an aging population and the shift to defined-contribution retirement solutions. Investors care because Corebridge sits at the intersection of predictable recurring cash (fees and annuity premiums), an above-average dividend yield, and a balance sheet that can be reshaped via reinsurance and M&A.

Numbers that matter

Those figures tell a mixed story. On one hand, price-to-book in the low single digits and a mid-single-digit dividend make Corebridge look inexpensive for an insurer with recurring premium and fee streams. On the other hand, EV/EBITDA at ~40x flags that reported operating profitability is currently depressed relative to enterprise value - a reflection of insurance accounting, capital adjustments and recent portfolio moves like variable-annuity reinsurance deals.

Operationally, the company has moved to de-risk variable annuity exposures in the past year and reported an adjusted EPS improvement historically - the firm reported adjusted EPS of $1.36 in Q2 2025, up 20% year-over-year as the company completed a material reinsurance transaction and strengthened its capital position. That is a constructive datapoint for earnings power once the capital structure is steady.

Valuation framing

At an enterprise value of roughly $22.9B versus a market cap near $12.0B, Corebridge's capital structure includes meaningful debt and insurance technical liabilities. The stock's price-to-book in the ~1.2x area and a dividend yield around 3.5% present a value proposition versus many financials that trade at richer multiples. If Corebridge can show stable underwriting and fee income, the market has scope for re-rating toward more normative insurance multiples.

That said, EV/EBITDA near 40x is high if you treat reported EBITDA as a normalized operating metric - much of that multiple reflects the insurer's transitional earnings shape and the market pricing of balance-sheet risk. In plain terms: the equity looks cheap on a book-value and dividend basis, but the earnings conversion and capital treatment leave valuation ambiguous until the merger and reinsurance moves settle out.

Catalysts

• Merger close process - The proposed $22B merger with Equitable Holdings is the biggest near-term catalyst. Any additional disclosures, revised terms, or regulatory feedback could move the stock materially.
• Legal/investor scrutiny - Halper Sadeh LLC's probe into whether shareholders are getting fair value is active; a resolution or change in deal terms would be a meaningful directional event.
• Earnings cadence - Follow-up quarters that show improved EPS conversion from recent reinsurance deals would support multiple expansion.
• Dividend & capital actions - Confirmation of a stable dividend policy and clearer capital return framework post-merger could re-rate the stock.
• RILA and product traction - Product innovations such as the MarketLock annuity and growth in RILA (registered index-linked annuity) sales would underpin fee growth in Individual Retirement.

Trade plan (actionable)

My trade is a conditional long with defined sizing: initiate a position at $26.00. Place a hard stop at $23.50 to limit downside if the deal unravels or disclosure surprises. Primary profit target is $31.00, with a secondary stretch target near $35.00 if the merger closes on favorable terms and earnings trajectory improves materially.

Horizon: mid term (45 trading days) is the primary lens. I expect material deal-related news or earnings tidbits across that window that will determine whether the position reaches the $31.00 target or needs reassessment. If the merger looks likely to close without material dilution or disclosure surprises, convert the position to a longer hold and look to the 180 trading day horizon for the $35.00 stretch target.

Size this as a core tactical holding but keep it modest relative to risk budget: the merger introduces event risk and potential binary outcomes, so position sizing should reflect that asymmetry.

Why this is reasonable

At $26.00 the market prices Corebridge at a modest P/B and offers a 3.5% yield. If management continues to reduce capital-intensive variable annuity exposure and the merger enhances scale or distribution without large incremental dilution, a move to the mid-$30s is plausible within months as investors re-assess earnings visibility and capital returns. The $23.50 stop respects the recent low-$22 level while giving the trade enough room for routine volatility.

Risks and counterarguments

• Deal execution risk - The merger with Equitable is the dominant binary risk. If the deal is re-priced, delayed, or scuttled, shares can underperform quickly. That is the primary reason for a hard stop.
• Legal/fiduciary pressure - Ongoing investigations or litigation could force additional disclosure, concessions or an increased consideration package that dilutes current shareholders more than expected.
• Accounting and earnings volatility - Insurance earnings are sensitive to reserve adjustments, investment spreads, and reinsurance outcomes. EV/EBITDA already implies the market expects limited near-term EBITDA uplift; any surprise reserve take or investment loss could be punished.
• Interest-rate and macro sensitivity - Life insurers and annuity providers are sensitive to long-term yields and inflation assumptions. A rapid adverse move in rates could widen hedging gaps or compress reinvestment yields.
• Competition and product risk - Product innovation (RILAs, fixed-index annuities) invites competition; market share shifts or pricing compression would hit fee income.

Counterargument: One could reasonably argue that the market is already discounting the best-case scenario and that the EV/EBITDA multiple reflects persistent capital drag and structural issues in earnings quality. If you believe Corebridge's earnings power will not materially improve after the merger - or that the combined firm will retain a complex liability profile that keeps capital returns constrained - then it's prudent to remain sidelined until the deal closes and one sees a clearer capital allocation path.

What would change my mind

I would close the position or move to neutral if any of the following occur: (1) the merger is re-priced materially downward or faces credible regulatory rejection, (2) management signals a materially weaker capital-return outlook post-merger, or (3) a quarter shows negative surprise in reserve development or investment losses that impairs leverage metrics. Conversely, I would increase conviction and size if the merger produces clearer synergies, management lays out explicit excess-capital returns, or successive quarters show improving adjusted EPS conversion from reinsurance actions.

Conclusion

Corebridge is a classic case of value with conditional execution. The balance sheet and dividend yield provide an attractive base; the Equitable merger and associated scrutiny create event-driven risk that could send the stock either higher or lower in the near term. For traders willing to accept event risk, initiate a controlled long at $26.00, protect the downside with a $23.50 stop, and look for $31.00 as a reasonable first objective over a mid-term (45 trading days) horizon. Keep position size conservative and be prepared to reassess on news flow tied to the merger and investor scrutiny.

Key tactical bullets

• Entry: $26.00
• Stop: $23.50
• Target: $31.00 (primary), $35.00 (stretch)
• Horizon: mid term (45 trading days) with conditional extension to long term (180 trading days) if deal fundamentals clear.